Pregled bibliografske jedinice broj: 1159716
ANTICOAGULANT THERAPY IN SECONDARY STROKE PREVENTION
ANTICOAGULANT THERAPY IN SECONDARY STROKE PREVENTION // ABSTRACT BOOK (International Neuropsychiatric Congress. Online)
Pula, Hrvatska, 2019. str. 88-88 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1159716 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
ANTICOAGULANT THERAPY IN SECONDARY STROKE PREVENTION
Autori
Budinčević, Hrvoje
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
ABSTRACT BOOK (International Neuropsychiatric Congress. Online)
/ - , 2019, 88-88
Skup
59. Međunarodni neuropsihijatrijski kongres (MIND & BRAIN)
Mjesto i datum
Pula, Hrvatska, 30.05.2019. - 02.06.2019
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
stroke prevention
Sažetak
Atrial fibrillation is well known risk factor for ischemic stroke. The oral anticoagulant therapy with vitamin K antagonists have been a gold standard for secondary prevention of cardioembolic stroke. Development and presence of direct oral anticoagulants (direct thrombin inhibitors and direct inhibitors of factor Xa) with at least similar efficacy and better safety profile included them into guidelines. Aspirin is the gold standard of prevention of noncardioembolic stroke, but it seems lost the role in primary stroke prevention, as well as in patients with non-valvular atrial fibrillation. The current dilemmas regarding usage of oral anticoagulant therapy will be discussed.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinička bolnica "Sveti Duh",
Medicinski fakultet, Osijek
Profili:
Hrvoje Budinčević
(autor)